Short, Nicholas J. http://orcid.org/0000-0002-2983-2738
Nguyen, Daniel
Ravandi, Farhad http://orcid.org/0000-0002-7621-377X
Article History
Received: 12 July 2023
Revised: 9 August 2023
Accepted: 24 August 2023
First Online: 11 September 2023
Competing interests
: NJS has served as consultant for Pfizer Inc., GSK, NKARTA, and Sanofi, reports receiving research grants from Takeda Oncology, Astellas Pharma Inc., Xencor, Stemline Therapeutics, and NextCure, and has received honoraria from Novartis, Amgen, Takeda Oncology, Astellas Pharma Inc., Sanofi, and BeiGene. FR has served as a consultant for AbbVie, reports receiving research grants from Astellas Pharma Inc. and Celgene/BMS, and has received honoraria from Astellas Pharma Inc. and Celgene/BMS. The other authors report no relevant conflicts of interest.